Transcriptomics Market - Global Outlook and Forecast 2022-2028

January 2022 | 73 pages | ID: T3093B949C76EN
Market Monitor Global

Abstracts

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics. The global transcriptomic market could see a whole lot of instances of new product launch. For example, Trio RNA-Seq launched by NuGEN Technologies, Inc. is particularly suited for low abundance transcripts applications as it offers an extremely sensitive whole transcriptomic solution. This innovation embodies three powerful technologies, viz. single primer isothermal amplification (SPIA), DimerFree, and AnyDeplete, for performing high sensitivity ribonucleic acid (RNA) analysis.

This report contains market size and forecasts of Transcriptomics in Global, including the following market information:

Global Transcriptomics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Transcriptomics market was valued at 3884.5 million in 2021 and is projected to reach US$ 7365.1 million by 2028, at a CAGR of 9.6% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transcriptomics include Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Transcriptomics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transcriptomics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Transcriptomics Market Segment Percentages, by Type, 2021 (%)

• PCR
• Microarray
• Sequencing

Global Transcriptomics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Transcriptomics Market Segment Percentages, by Application, 2021 (%)

• Pharmaceutical and Biotechnology
• Academic Research and Government Institutes
• Hospitals and Diagnostic Centers

Global Transcriptomics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Transcriptomics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transcriptomics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Transcriptomics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Thermo Fisher Scientific
• Illumina
• QIAGEN (Exiqon)
• Agilent Technologies
• Roche
• GE Healthcare
• Bio-Rad Laboratories
• Fluidigm

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Transcriptomics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Transcriptomics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TRANSCRIPTOMICS OVERALL MARKET SIZE

2.1 Global Transcriptomics Market Size: 2021 VS 2028
2.2 Global Transcriptomics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Transcriptomics Players in Global Market
3.2 Top Global Transcriptomics Companies Ranked by Revenue
3.3 Global Transcriptomics Revenue by Companies
3.4 Top 3 and Top 5 Transcriptomics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Transcriptomics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Transcriptomics Players in Global Market
  3.6.1 List of Global Tier 1 Transcriptomics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Transcriptomics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Transcriptomics Market Size Markets, 2021 & 2028
  4.1.2 PCR
  4.1.3 Microarray
  4.1.4 Sequencing
4.2 By Type - Global Transcriptomics Revenue & Forecasts
  4.2.1 By Type - Global Transcriptomics Revenue, 2017-2022
  4.2.2 By Type - Global Transcriptomics Revenue, 2023-2028
  4.2.3 By Type - Global Transcriptomics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Transcriptomics Market Size, 2021 & 2028
  5.1.2 Pharmaceutical and Biotechnology
  5.1.3 Academic Research and Government Institutes
  5.1.4 Hospitals and Diagnostic Centers
5.2 By Application - Global Transcriptomics Revenue & Forecasts
  5.2.1 By Application - Global Transcriptomics Revenue, 2017-2022
  5.2.2 By Application - Global Transcriptomics Revenue, 2023-2028
  5.2.3 By Application - Global Transcriptomics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Transcriptomics Market Size, 2021 & 2028
6.2 By Region - Global Transcriptomics Revenue & Forecasts
  6.2.1 By Region - Global Transcriptomics Revenue, 2017-2022
  6.2.2 By Region - Global Transcriptomics Revenue, 2023-2028
  6.2.3 By Region - Global Transcriptomics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Transcriptomics Revenue, 2017-2028
  6.3.2 US Transcriptomics Market Size, 2017-2028
  6.3.3 Canada Transcriptomics Market Size, 2017-2028
  6.3.4 Mexico Transcriptomics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Transcriptomics Revenue, 2017-2028
  6.4.2 Germany Transcriptomics Market Size, 2017-2028
  6.4.3 France Transcriptomics Market Size, 2017-2028
  6.4.4 U.K. Transcriptomics Market Size, 2017-2028
  6.4.5 Italy Transcriptomics Market Size, 2017-2028
  6.4.6 Russia Transcriptomics Market Size, 2017-2028
  6.4.7 Nordic Countries Transcriptomics Market Size, 2017-2028
  6.4.8 Benelux Transcriptomics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Transcriptomics Revenue, 2017-2028
  6.5.2 China Transcriptomics Market Size, 2017-2028
  6.5.3 Japan Transcriptomics Market Size, 2017-2028
  6.5.4 South Korea Transcriptomics Market Size, 2017-2028
  6.5.5 Southeast Asia Transcriptomics Market Size, 2017-2028
  6.5.6 India Transcriptomics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Transcriptomics Revenue, 2017-2028
  6.6.2 Brazil Transcriptomics Market Size, 2017-2028
  6.6.3 Argentina Transcriptomics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Transcriptomics Revenue, 2017-2028
  6.7.2 Turkey Transcriptomics Market Size, 2017-2028
  6.7.3 Israel Transcriptomics Market Size, 2017-2028
  6.7.4 Saudi Arabia Transcriptomics Market Size, 2017-2028
  6.7.5 UAE Transcriptomics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Corporate Summary
  7.1.2 Thermo Fisher Scientific Business Overview
  7.1.3 Thermo Fisher Scientific Transcriptomics Major Product Offerings
  7.1.4 Thermo Fisher Scientific Transcriptomics Revenue in Global Market (2017-2022)
  7.1.5 Thermo Fisher Scientific Key News
7.2 Illumina
  7.2.1 Illumina Corporate Summary
  7.2.2 Illumina Business Overview
  7.2.3 Illumina Transcriptomics Major Product Offerings
  7.2.4 Illumina Transcriptomics Revenue in Global Market (2017-2022)
  7.2.5 Illumina Key News
7.3 QIAGEN (Exiqon)
  7.3.1 QIAGEN (Exiqon) Corporate Summary
  7.3.2 QIAGEN (Exiqon) Business Overview
  7.3.3 QIAGEN (Exiqon) Transcriptomics Major Product Offerings
  7.3.4 QIAGEN (Exiqon) Transcriptomics Revenue in Global Market (2017-2022)
  7.3.5 QIAGEN (Exiqon) Key News
7.4 Agilent Technologies
  7.4.1 Agilent Technologies Corporate Summary
  7.4.2 Agilent Technologies Business Overview
  7.4.3 Agilent Technologies Transcriptomics Major Product Offerings
  7.4.4 Agilent Technologies Transcriptomics Revenue in Global Market (2017-2022)
  7.4.5 Agilent Technologies Key News
7.5 Roche
  7.5.1 Roche Corporate Summary
  7.5.2 Roche Business Overview
  7.5.3 Roche Transcriptomics Major Product Offerings
  7.5.4 Roche Transcriptomics Revenue in Global Market (2017-2022)
  7.5.5 Roche Key News
7.6 GE Healthcare
  7.6.1 GE Healthcare Corporate Summary
  7.6.2 GE Healthcare Business Overview
  7.6.3 GE Healthcare Transcriptomics Major Product Offerings
  7.6.4 GE Healthcare Transcriptomics Revenue in Global Market (2017-2022)
  7.6.5 GE Healthcare Key News
7.7 Bio-Rad Laboratories
  7.7.1 Bio-Rad Laboratories Corporate Summary
  7.7.2 Bio-Rad Laboratories Business Overview
  7.7.3 Bio-Rad Laboratories Transcriptomics Major Product Offerings
  7.7.4 Bio-Rad Laboratories Transcriptomics Revenue in Global Market (2017-2022)
  7.7.5 Bio-Rad Laboratories Key News
7.8 Fluidigm
  7.8.1 Fluidigm Corporate Summary
  7.8.2 Fluidigm Business Overview
  7.8.3 Fluidigm Transcriptomics Major Product Offerings
  7.8.4 Fluidigm Transcriptomics Revenue in Global Market (2017-2022)
  7.8.5 Fluidigm Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Transcriptomics Market Opportunities & Trends in Global Market
Table 2. Transcriptomics Market Drivers in Global Market
Table 3. Transcriptomics Market Restraints in Global Market
Table 4. Key Players of Transcriptomics in Global Market
Table 5. Top Transcriptomics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Transcriptomics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Transcriptomics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Transcriptomics Product Type
Table 9. List of Global Tier 1 Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Transcriptomics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Transcriptomics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Transcriptomics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Transcriptomics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Transcriptomics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Transcriptomics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Transcriptomics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Transcriptomics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Transcriptomics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Transcriptomics Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Transcriptomics Product Offerings
Table 32. Thermo Fisher Scientific Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 33. Illumina Corporate Summary
Table 34. Illumina Transcriptomics Product Offerings
Table 35. Illumina Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 36. QIAGEN (Exiqon) Corporate Summary
Table 37. QIAGEN (Exiqon) Transcriptomics Product Offerings
Table 38. QIAGEN (Exiqon) Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 39. Agilent Technologies Corporate Summary
Table 40. Agilent Technologies Transcriptomics Product Offerings
Table 41. Agilent Technologies Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Transcriptomics Product Offerings
Table 44. Roche Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 45. GE Healthcare Corporate Summary
Table 46. GE Healthcare Transcriptomics Product Offerings
Table 47. GE Healthcare Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 48. Bio-Rad Laboratories Corporate Summary
Table 49. Bio-Rad Laboratories Transcriptomics Product Offerings
Table 50. Bio-Rad Laboratories Transcriptomics Revenue (US$, Mn), (2017-2022)
Table 51. Fluidigm Corporate Summary
Table 52. Fluidigm Transcriptomics Product Offerings
Table 53. Fluidigm Transcriptomics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Transcriptomics Segment by Type in 2021
Figure 2. Transcriptomics Segment by Application in 2021
Figure 3. Global Transcriptomics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Transcriptomics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Transcriptomics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Transcriptomics Revenue in 2021
Figure 8. By Type - Global Transcriptomics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Transcriptomics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Transcriptomics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Transcriptomics Revenue Market Share, 2017-2028
Figure 12. US Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Transcriptomics Revenue Market Share, 2017-2028
Figure 16. Germany Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 17. France Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Transcriptomics Revenue Market Share, 2017-2028
Figure 24. China Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 28. India Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Transcriptomics Revenue Market Share, 2017-2028
Figure 30. Brazil Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Transcriptomics Revenue Market Share, 2017-2028
Figure 33. Turkey Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Transcriptomics Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Illumina Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. QIAGEN (Exiqon) Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Agilent Technologies Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GE Healthcare Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bio-Rad Laboratories Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Fluidigm Transcriptomics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)